Default company panoramic image
Logo

Bioquark Inc.

Bioquark, Inc. is a biopharmaceutical company developing proprietary biologicals for regeneration and repair of human organs and tissues.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2008
  • Employees 5
  • Website bioquark.com

Company Summary

The company’s core program is focused on the development of biologics capable of directly remodeling diseased, damaged, or aged tissues, creating micro-environments that induce efficient and controllable regeneration and repair. Through this novel approach, we are capable of creating conditions in mature tissues that are normally only seen during human fetal development, as well as during limb and organ regeneration in organisms like amphibians.

Team

  • Default avatar
    Ira S Pastor
    CEO
    Unconfirmed

    25 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior

  • Default avatar
    Sergei Paylian
    Founder / Chief Scientific Officer
    Unconfirmed

    Over 30 years of extensive research and administrative experience in the biomedical sciences including: molecular biology, genetics, immunology, immunohistochemistry, virology, experimental gerontology, oncology, pharmacology, microbiology, physiology, electrophysiology, and stem cell biology; Developed breakthrough technology in human somatic cell reprogramming (U.S. Patents pending), as well as precursor microincubator technology (Use of Xenop

Advisors

  • Default avatar
    JS Barkats PLLC
    Lawyer
    Unconfirmed